Warner Chilcott plc (WCRX)
-NasdaqGS 19.21 
0.07(0.36%) 18 May 04:00 SGT|After Hours
:
19.25 0.04 (0.21%) 18 May 04:13 SGT
| Prev Close: | 19.28 |
|---|
| Open: | 19.44 |
|---|
| Bid: | 19.20 x 500 |
|---|
| Ask: | 19.39 x 500 |
|---|
| 1y Target Est: | 20.53 |
|---|
| Beta: | 1.37 |
|---|
| Next Earnings Date: | 31-Jul-13 |
|---|
| Day's Range: | 18.88 - 19.60 |
|---|
| 52wk Range: | 10.85 - 20.51 |
|---|
| Volume: | 14,125,841 |
|---|
| Avg Vol (3m): | 5,016,670 |
|---|
| Market Cap: | 4.82B |
|---|
| P/E (ttm): | 11.93 |
|---|
| EPS (ttm): | 1.61 |
|---|
| Div & Yield: | 0.50 (2.60%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Actavis Could Lower Tax Rate With Warner Chilcott Dealat The Wall Street Journal(Sat, 18 May)
- Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Sat, 18 May)
- WARNER CHILCOTT PLC FinancialsEDGAR Online Financials(Sat, 18 May)
- DEALTALK: Warner Chilcott buy may be Actavis' best takeover defenseat Reuters(Sat, 18 May)
- Innovative Therapeutic Development for Duchenne Muscular Dystrophy Moves Niche Stocks Up 300% to 400%: An Expert Portfolio Manager Discusses Investing in Health CareWall Street Transcript(Fri, 17 May)
- Drugmaker Actavis' shares upAP(Thu, 16 May)
- Ahead of the Bell: Drugmaker Actavis' shares upAP(Thu, 16 May)
- Ahead of the Bell: Warner ChilcottAP(Mon, 13 May)
- Actavis, Warner Chilcott discussing combinationAP(Sat, 11 May)
- Warner Chilcott 1Q net income holds steadyAP(Sat, 11 May)
Key Statistics
| Forward P/E (1 yr): | 6.10 |
|---|
| P/S (ttm): | 1.97 |
|---|
| Ex-Dividend Date: | 29-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.34 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.84 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | -57.70 |
|---|
Business Summary
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the womens healthcare, gastroenterology, urology, an...
View More